how common are glp 1 side effects A monthly GLP-1 dose could cut the number of shots patients take each year from 52 to 12. from the drug — mainly gastrointestinal symptoms — were similar to or Glucagon-like Receptor-1 agonists for obesity:

Concomitant antidiabetic therapies were frequently reported, with metformin being the most frequently reported concomitant medication (n = 1,879), followed by pioglitazone (n = 478), insulin glargine (n = 474), glipizide (n = 467), and glimepiride (n = 345) (Figure S1)

These include improving vascular function, reducing systemic inflammation, enhancing coronary microvascular function, and mitigating comorbid conditions like metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney disease (CKD)

10 Biggest Mistakes People Make on GLP-1 Medications (Ozempic, Mounjaro, Wegovy, Zepbound) 1

How Wegovy slows appetite research explained